Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function
Khatri, B O, Man, S, Giovannoni, G, Koo, A P, Lee, J-C, Tucky, B, Lynn, F, Jurgensen, S, Woodworth, J, Goelz, S, Duda, P W, Panzara, M A, Ransohoff, R M, Fox, R J
Published in Neurology (03.02.2009)
Published in Neurology (03.02.2009)
Get more information
Journal Article
Clinical pharmacology of alemtuzumab, an anti‐CD52 immunomodulator, in multiple sclerosis
Li, Z., Richards, S., Surks, H. K., Jacobs, A., Panzara, M. A.
Published in Clinical and experimental immunology (01.12.2018)
Published in Clinical and experimental immunology (01.12.2018)
Get full text
Journal Article
Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire
Benedict, RHB, Duquin, JA, Jurgensen, S, Rudick, RA, Feitcher, J, Munschauer, FE, Panzara, MA, Weinstock-Guttman, B
Published in Multiple sclerosis (01.08.2008)
Published in Multiple sclerosis (01.08.2008)
Get full text
Journal Article
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS
Miller, D H, Soon, D, Fernando, K T, MacManus, D G, Barker, G J, Yousry, T A, Fisher, E, O'Connor, P W, Phillips, J T, Polman, C H, Kappos, L, Hutchinson, M, Havrdova, E, Lublin, F D, Giovannoni, G, Wajgt, A, Rudick, R, Lynn, F, Panzara, M A, Sandrock, A W
Published in Neurology (24.04.2007)
Published in Neurology (24.04.2007)
Get more information
Journal Article
GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study
Goodman, A D, Rossman, H, Bar-Or, A, Miller, A, Miller, D H, Schmierer, K, Lublin, F, Khan, O, Bormann, N M, Yang, M, Panzara, M A, Sandrock, A W
Published in Neurology (03.03.2009)
Published in Neurology (03.03.2009)
Get more information
Journal Article
Progressive MS Alliance Industry Forum: Maximizing Collective Impact To Enable Drug Development
Zaratin, P, Comi, G, Coetzee, T, Ramsey, K, Smith, K, Thompson, A, Panzara, M
Published in Trends in pharmacological sciences (Regular ed.) (01.10.2016)
Published in Trends in pharmacological sciences (Regular ed.) (01.10.2016)
Get full text
Journal Article
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL
Hutchinson, M., Kappos, L., Calabresi, P. A., Confavreux, C., Giovannoni, G., Galetta, S. L., Havrdova, E., Lublin, F. D., Miller, D. H., O’Connor, P. W., Phillips, J. T., Polman, C. H., Radue, E.-W., Rudick, R. A., Stuart, W. H., Wajgt, A., Weinstock-Guttman, B., Wynn, D. R., Lynn, F., Panzara, M. A.
Published in Journal of neurology (01.03.2009)
Published in Journal of neurology (01.03.2009)
Get full text
Journal Article
Assessing disability progression with the Multiple Sclerosis Functional Composite
Rudick, RA, Polman, CH, Cohen, JA, Walton, MK, Miller, AE, Confavreux, C, Lublin, FD, Hutchinson, M, O’Connor, PW, Schwid, SR, Balcer, LJ, Lynn, F, Panzara, MA, Sandrock, AW
Published in Multiple sclerosis (01.08.2009)
Published in Multiple sclerosis (01.08.2009)
Get full text
Journal Article
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis
Balcer, L J, Galetta, S L, Calabresi, P A, Confavreux, C, Giovannoni, G, Havrdova, E, Hutchinson, M, Kappos, L, Lublin, F D, Miller, D H, O'Connor, P W, Phillips, J T, Polman, C H, Radue, E-W, Rudick, R A, Stuart, W H, Wajgt, A, Weinstock-Guttman, B, Wynn, D R, Lynn, F, Panzara, M A
Published in Neurology (17.04.2007)
Published in Neurology (17.04.2007)
Get more information
Journal Article
Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a
Rudick, R A, Pace, A, Rani, M R S, Hyde, R, Panzara, M, Appachi, S, Shrock, J, Maurer, S L, Calabresi, P A, Confavreux, C, Galetta, S L, Lublin, F D, Radue, E-W, Ransohoff, R M
Published in Neurology (09.06.2009)
Published in Neurology (09.06.2009)
Get more information
Journal Article
Infusion-related hypersensitivity reactions during natalizumab treatment
Phillips, J T, O'Connor, P W, Havrdova, E, Hutchinson, M, Kappos, L, Miller, D H, Polman, C H, Lublin, F D, Giovannoni, G, Wajgt, A, Lynn, F, Panzara, M A, Sandrock, A W
Published in Neurology (14.11.2006)
Published in Neurology (14.11.2006)
Get more information
Journal Article
Alemtuzumab treatment has no adverse impact on sperm quality, quantity, or motility: A CARE-MS substudy
Margolin, D.H, Rizzo, M.A, Smith, G, Arnold, D.L, Cohen, J.A, Coles, A.J, Confavreux, C, Fox, E.J, Hartung, H.-P, Havrdova, E, Selmaj, K.W, Weiner, H.L, Brinar, V, Giovannoni, G, Miller, T.A, Stojanovic, M, Twyman, C.L, Lake, S.L, Panzara, M, Compston, D.A.S
Published in Journal of the neurological sciences (15.10.2013)
Published in Journal of the neurological sciences (15.10.2013)
Get full text
Journal Article
Adverse event profile of alemtuzumab over time in treatment-naïve patients with early, active relapsing–/INS;remitting multiple sclerosis (RRMS; CARE-MS I study)
Lycke, J, Arnold, D.L, Cohen, J.A, Coles, A.J, Confavreux, C, Fox, E.J, Hartung, H.-P, Havrdova, E, Selmaj, K.W, Weiner, H.L, Brinar, V, Giovannoni, G, Stojanovic, M, Lake, S.L, Margolin, D.H, Panzara, M, Compston, D.A.S
Published in Journal of the neurological sciences (15.10.2013)
Published in Journal of the neurological sciences (15.10.2013)
Get full text
Journal Article
Alemtuzumab improves visual outcomes in treatment-naïve patients with relapsing–/INS;remitting multiple sclerosis (RRMS): Analysis from the phase 3 CARE-MS I study
Balcer, L.J, Arnold, D.L, Cohen, J.A, Coles, A.J, Confavreux, C, Fox, E.J, Hartung, H.-P, Havrdova, E, Selmaj, K.W, Weiner, H.L, Brinar, V, Giovannoni, G, Stojanovic, M, Cinar, A, Margolin, D.H, Panzara, M, Compston, D.A.S
Published in Journal of the neurological sciences (15.10.2013)
Published in Journal of the neurological sciences (15.10.2013)
Get full text
Journal Article
Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis
Oksenberg, Jorge R, Panzara, Michael A, Begovich, Ann B, Mitchell, Dennis, Erlich, Henry A, Murray, Ronald S, Shimonkevitz, Richard, Sherritt, Martina, Rothbard, Jonathan, Bernard, Claude C. A, Steinman, Lawrence
Published in Nature (London) (04.03.1993)
Published in Nature (London) (04.03.1993)
Get full text
Journal Article
P22 WVE-N531 yields 53% mean exon 53 skipping in skeletal muscle of boys with Duchenne muscular dystrophy (DMD) after three biweekly doses
Tillinger, M., Lake, S., Servais, L., Campbell, C., Xu, X., Hart, A., Haegele, J., Singh, K., Rheinhardt, J., Ghosh, A., Xu, D., Panzara, M., Li-Kwai-Cheung, A.
Published in Neuromuscular disorders : NMD (01.10.2023)
Published in Neuromuscular disorders : NMD (01.10.2023)
Get full text
Journal Article
FP.12 Application for primary endpoint qualification of the 95th centile of stride velocity (SV95C) in Duchenne muscular dystrophy
Annoussamy, M., Eggenspieler, D., Seferian, A., Mercuri, E., Straub, V., Muntoni, F., Scoto, M., Poleur, M., Daron, A., Butoianu, N., Mirea, A., Goemans, N., Previtali, S., Tulinius, M., Nascimento, A., Heydemann, P., Panzara, M., Singh, T., Strijbos, P., Servais, L.
Published in Neuromuscular disorders : NMD (01.10.2022)
Published in Neuromuscular disorders : NMD (01.10.2022)
Get full text
Journal Article
EP.83Design of a Phase 2/3 randomized controlled trial of suvodirsen (WVE-210201) in patients with Duchenne muscular dystrophy amenable to exon 51 skipping
Wagner, K., Cripe, L., Eagle, M., Muntoni, F., Niks, E., Phan, H., Straub, V., Hu, X., Antonijevic, I., Berry, S., Quintana, M., Lake, S., Panzara, M.
Published in Neuromuscular disorders : NMD (01.10.2019)
Published in Neuromuscular disorders : NMD (01.10.2019)
Get full text
Journal Article
O.28Safety and tolerability of suvodirsen (WVE-210201) in patients with Duchenne muscular dystrophy: results from a phase 1 clinical trial
Wagner, K., Phan, H., Servais, L., Gidaro, T., Cripe, L., Eagle, M., Muntoni, F., Straub, V., Lonkar, P., Schmitz, S., Lake, S., Hu, X., Panzara, M.
Published in Neuromuscular disorders : NMD (01.10.2019)
Published in Neuromuscular disorders : NMD (01.10.2019)
Get full text
Journal Article